|
Volumn 19, Issue 1, 2002, Pages 237-251
|
Circadian chemotherapy for gynecological and genitourinary cancers
|
Author keywords
Chemotherapy; Chronotherapy; Circadian rhythm; Genitourinary cancer; Gynecological cancer
|
Indexed keywords
ALPHA INTERFERON;
ANTHRACYCLINE;
CARBOPLATIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DNA;
DOXORUBICIN;
FLOXURIDINE;
FLUOROPYRIMIDINE;
FLUOROURACIL;
INTERLEUKIN 2;
PIRARUBICIN;
PLATINUM;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BLADDER CANCER;
BONE MARROW TOXICITY;
CANCER CHEMOTHERAPY;
CANCER SURVIVAL;
CIRCADIAN RHYTHM;
CLINICAL TRIAL;
DNA SYNTHESIS;
DRUG EFFICACY;
ENDOMETRIUM CANCER;
GASTROINTESTINAL TOXICITY;
GYNECOLOGIC CANCER;
HUMAN;
KIDNEY CARCINOMA;
LEUKOPENIA;
MITOSIS;
NEPHROTOXICITY;
NEUROTOXICITY;
NONHUMAN;
OVARY CANCER;
THROMBOCYTOPENIA;
UROGENITAL TRACT CANCER;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CARCINOMA, RENAL CELL;
CELL CYCLE;
CHRONOTHERAPY;
CIRCADIAN RHYTHM;
CISPLATIN;
DOXORUBICIN;
ENDOMETRIAL NEOPLASMS;
FEMALE;
FLOXURIDINE;
GENITAL NEOPLASMS, FEMALE;
HUMANS;
KIDNEY NEOPLASMS;
MALE;
OVARIAN NEOPLASMS;
PROSTATIC NEOPLASMS;
RATS;
URINARY BLADDER NEOPLASMS;
UROGENITAL NEOPLASMS;
|
EID: 0036227308
PISSN: 07420528
EISSN: None
Source Type: Journal
DOI: 10.1081/CBI-120002600 Document Type: Article |
Times cited : (82)
|
References (33)
|